EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -33.3% | 70 | +9.4% | 0.00% | – |
Q2 2022 | $3,000 | -25.0% | 64 | -16.9% | 0.00% | – |
Q1 2022 | $4,000 | +100.0% | 77 | +126.5% | 0.00% | – |
Q3 2021 | $2,000 | +100.0% | 34 | +100.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 17 | -45.2% | 0.00% | – |
Q1 2021 | $1,000 | -50.0% | 31 | -40.4% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 52 | +23.8% | 0.00% | – |
Q3 2020 | $2,000 | – | 42 | +425.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 8 | -98.9% | 0.00% | -100.0% |
Q4 2019 | $44,000 | +266.7% | 741 | +233.8% | 0.00% | +200.0% |
Q3 2019 | $12,000 | +500.0% | 222 | +441.5% | 0.00% | – |
Q2 2019 | $2,000 | -98.6% | 41 | -98.0% | 0.00% | -100.0% |
Q3 2018 | $146,000 | -99.9% | 2,097 | +12.4% | 0.01% | -8.3% |
Q2 2018 | $141,183,000 | +470510.0% | 1,866 | +232.6% | 0.01% | +300.0% |
Q1 2018 | $30,000 | +233.3% | 561 | +208.2% | 0.00% | +200.0% |
Q4 2017 | $9,000 | -82.0% | 182 | -78.4% | 0.00% | -80.0% |
Q3 2017 | $50,000 | -12.3% | 842 | +16.6% | 0.01% | 0.0% |
Q2 2017 | $57,000 | +1325.0% | 722 | +1237.0% | 0.01% | – |
Q1 2017 | $4,000 | 0.0% | 54 | 0.0% | 0.00% | – |
Q4 2016 | $4,000 | -91.3% | 54 | -95.5% | 0.00% | -100.0% |
Q2 2016 | $46,000 | -82.6% | 1,197 | -81.7% | 0.00% | -84.0% |
Q1 2016 | $264,000 | -86.7% | 6,524 | -70.8% | 0.02% | -86.0% |
Q4 2015 | $1,980,000 | – | 22,334 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |